The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...
Ozempic isn’t the only drug that mimics the natural GLP-1 hormone, so users feel fuller for longer and eat less. There’s also ...
New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime ...
“For decades, the diabetes world has focused on lowering sugar, not on treating the root cause of the disease nor on stopping its progression” said Dr. Dror Chevion, co-founder and CEO of Concenter ...
Alexander Zverev booked a third straight Australian Open semifinal on Tuesday, outlasting Learner Tien 6-3, 6-7(5), 6-1, ...
MannKind (Nasdaq:MNKD) announced today that it received FDA approval, updating the prescribing information for Afrezza ...
Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...
For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation ...
Dr Anne Peters discusses updates in the ADA 2026 Standards of Care in Diabetes, focusing on the use of technology.
For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation in the digestive tract and the absence of a dedicated intestinal transport ...
KGUN 9 Tucson, AZ on MSN
Managing diabetes with fewer shots: how inhaled insulin works
Inhaled insulin works quickly at meals and may reduce injections for some adults with diabetes.
The FDA has cleared the first app that integrates glucose data with multiple daily injection (MDI) insulin dosing for people with diabetes. Features include real-time glucose data, dose calculations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results